310 related articles for article (PubMed ID: 19328636)
1. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation.
Parsons A; Ingram J; Inglis J; Aveyard P; Johnstone E; Brown K; Franklin M; Bermudez I
Drug Alcohol Depend; 2009 Jun; 102(1-3):116-22. PubMed ID: 19328636
[TBL] [Abstract][Full Text] [Related]
2. A Phase II study of St. John's Wort for smoking cessation.
Lawvere S; Mahoney MC; Cummings KM; Kepner JL; Hyland A; Lawrence DD; Murphy JM
Complement Ther Med; 2006 Sep; 14(3):175-84. PubMed ID: 16911897
[TBL] [Abstract][Full Text] [Related]
3. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
Barnes J; Barber N; Wheatley D; Williamson EM
Planta Med; 2006 Mar; 72(4):378-82. PubMed ID: 16557483
[TBL] [Abstract][Full Text] [Related]
4. A comparison of sustained-release bupropion and placebo for smoking cessation.
Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
[TBL] [Abstract][Full Text] [Related]
5. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
[TBL] [Abstract][Full Text] [Related]
8. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
Anthenelli RM; Blom TJ; McElroy SL; Keck PE
Addiction; 2008 Apr; 103(4):687-94. PubMed ID: 18339115
[TBL] [Abstract][Full Text] [Related]
9. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
Sarris J; Kavanagh DJ; Deed G; Bone KM
Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
[TBL] [Abstract][Full Text] [Related]
10. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
Hajek P; Tønnesen P; Arteaga C; Russ C; Tonstad S
Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
[TBL] [Abstract][Full Text] [Related]
11. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
Nørregaard J; Jørgensen S; Mikkelsen KL; Tønnesen P; Iversen E; Sørensen T; Søeberg B; Jakobsen HB
Clin Pharmacol Ther; 1996 Dec; 60(6):679-86. PubMed ID: 8988071
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of St. John's wort for smoking cessation.
Sood A; Ebbert JO; Prasad K; Croghan IT; Bauer B; Schroeder DR
J Altern Complement Med; 2010 Jul; 16(7):761-7. PubMed ID: 20590478
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.
Wagena EJ; Knipschild PG; Huibers MJ; Wouters EF; van Schayck CP
Arch Intern Med; 2005 Oct; 165(19):2286-92. PubMed ID: 16246996
[TBL] [Abstract][Full Text] [Related]
14. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.
Müller T; Mannel M; Murck H; Rahlfs VW
Psychosom Med; 2004; 66(4):538-47. PubMed ID: 15272100
[TBL] [Abstract][Full Text] [Related]
15. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
16. A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women.
Cooper TV; Klesges RC; Debon MW; Zbikowski SM; Johnson KC; Clemens LH
Addict Behav; 2005 Jan; 30(1):61-75. PubMed ID: 15561449
[TBL] [Abstract][Full Text] [Related]
17. Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Sood A; Ebbert JO; Clark MM; Croghan IT; Schroeder DR; Hays JT
Nicotine Tob Res; 2009 Dec; 11(12):1479-84. PubMed ID: 19884116
[TBL] [Abstract][Full Text] [Related]
18. Is concern about post-cessation weight gain a barrier to smoking cessation among pregnant women?
Berg CJ; Park ER; Chang Y; Rigotti NA
Nicotine Tob Res; 2008 Jul; 10(7):1159-63. PubMed ID: 18629725
[TBL] [Abstract][Full Text] [Related]
19. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
Schneider NG; Olmstead RE; Steinberg C; Sloan K; Daims RM; Brown HV
Clin Pharmacol Ther; 1996 Nov; 60(5):568-75. PubMed ID: 8941030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]